Unbound MEDLINE

Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. Journal of controlled release : official journal of the Controlled Release Society [J Control Release] Journal article

 
TitleContact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.
Author(s)Simberg D, Zhang WM, Merkulov S, McCrae K, Park JH, Sailor MJ, Ruoslahti E 
InstitutionNano Tumor Center of Excellence for Cancer Nanotechnology, Moores UCSD Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093 USA.
SourceJ Control Release 2009 Jun 6.
AbstractPreviously we reported that plasma kallikrein and high molecular weight kininogen attach to the surface of dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) through the incompletely covered iron oxide core (Simberg et al., Biomaterials, 2009). Here we show that SPIONs also activate kallikrein-kinin system in vitro and in vivo. The serine protease activity of kallikrein was stably associated with SPIONs and could be detected on the nanoparticles even after extensive washing steps. The enzymatic activity was not detectable in kininogen-deficient and Factor XII-deficient plasma. The enzymatic activation could be blocked by precoating SPIONs with histidine-rich Domain 5 (D5) of kininogen. Importantly, the kallikrein activity was detectable in plasma of SPION-injected, but not of D5/SPION-injected mice. Tumor-targeted SPIONs when injected into kininogen-deficient and control mice, produced high levels of vascular clotting in tumors, suggesting that kallikrein activation is not responsible for the nanoparticle-induced thrombosis. These data could help in understanding the toxicity of nanomaterials and could be used in designing nanoparticles with controlled enzymatic activity.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19508879
  
Advertise on this site.